CAS 63968-75-2
:4-chloro-N-(2-méthyl-1H-indol-1-yl)-3-sulfamoylbenzamide
Indapamide Related Compound A (4-chloro-N-(2-methyl-1H-indol-1-yl)-3-sulfamoylbenzamide)
CAS :Sulfonamides, nesoiFormule :C16H14ClN3O3SCouleur et forme :Yellow Brown PowderMasse moléculaire :363.04444INDAPAMIDE RELATED COMPOUND A (50 MG) (4-CHLORO-N-(2-METHYL-INDOL-1-YL)-3-SULFAMOYLBEN-ZAMIDE) (AS)
CAS :Formule :C16H14ClN3O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :363.8187Indapamide EP Impurity B (Indapamide USP Related Compound A, Dehydro Indapamide)
CAS :Formule :C16H14ClN3O3SCouleur et forme :White To Off-White SolidMasse moléculaire :363.834-Chloro-N-(2-methyl-1H-indol-1-yl)-3-sulphamoylbenzamide
CAS :Produit contrôléFormule :C16H14ClN3O3SCouleur et forme :NeatMasse moléculaire :363.82Indapamide
CAS :Produit contrôléFormule :C16H14ClN3O3SCouleur et forme :NeatMasse moléculaire :363.82Dehydro Indapamide
CAS :Produit contrôléImpurity Indapamide USP Related Compound A/ Indapamide EP Impurity B
Applications A metabolite of Indapamide (M5). A dehydrogenation pathway by cytochromes P450. Indapamide USP Related Compound A
References Tamura A., et al.: Chem. Pharm. Bull., 38, 225 (1990), Harlow, G.R., et al.: J. Biol. Chem., 272, 5396 (1997), Ozden, T., et al.: Pharm. Pharmacol. Commun., 4, 397 (1998), Gruciani, G., et al.: J. Med. Chem., 48, 6970 (2005), Sun, H., et al.: Drug. Metab. Dispos., 37, 672 (2009),Formule :C16H14ClN3O3SCouleur et forme :White To Light BrownMasse moléculaire :363.82Dehydroindapamide
CAS :Dehydroindapamide, an indole form of Indapamide, is utilized to quantify the turnover rate of Indapamide in CYP3A4, which is approximately 10 times higher than that of Indoline, with slightly enhanced affinity for CYP3A4.Formule :C16H14ClN3O3SCouleur et forme :SolidMasse moléculaire :363.82Dehydro indapamide
CAS :Dehydro indapamide is a drug that belongs to the class of antihypertensive agents. It is a prodrug that is metabolized in vivo to indapamide and hydrochlorothiazide. Dehydro indapamide has been shown to be efficacious in the treatment of hypertension, and it has a pharmacokinetic profile similar to other diuretics. The clinical data for this drug are limited, but there have been no serious side effects reported with its use.
Formule :C16H14ClN3O3SDegré de pureté :Min. 95%Masse moléculaire :363.82 g/mol










